Evidence map›Paper›PMID 39913691›Full record

ArticleBlood advances2025

Acute obstetric coagulopathy is associated with excess plasmin generation and proteolysis of fibrinogen and factor V.

Peter W Collins, Claire S Whyte, Lucy de Lloyd, Anuj Narwal, Sarah F Bell, Nicholas Gill, Rachel E Collis, Peter V Jenkins, Nicola J Mutch

Abstract read
In one paragraph

Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Peter W CollinsInstitute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0002-6410-1324
Claire S WhyteAberdeen Diabetes and Cardiovascular Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0001-8127-6102
Lucy de LloydDepartment of Anaesthetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom.ORCID 0000-0002-4625-3260
Anuj NarwalAberdeen Diabetes and Cardiovascular Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0002-5917-5716
Sarah F BellDepartment of Anaesthetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom.ORCID 0000-0003-0476-1360
Nicholas GillDepartment of Anaesthetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom.
Rachel E CollisDepartment of Anaesthetics, Cardiff and Vale University Health Board, University Hospital of Wales, Cardiff, United Kingdom.
Peter V JenkinsInstitute of Infection and Immunity, School of Medicine, Cardiff University, Cardiff, United Kingdom.ORCID 0000-0001-5301-464X
Nicola J MutchAberdeen Diabetes and Cardiovascular Centre, Institute of Medical Sciences, School of Medicine, Medical Sciences and Nutrition, University of Aberdeen, Aberdeen, United Kingdom.ORCID 0000-0002-7452-0813

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractHemostatic impairment may exacerbate postpartum hemorrhage (PPH). Previously, we described a distinct coagulopathy, associated with multiple causes of PPH including placental abruption and amniotic fluid embolus, termed acute obstetric coagulopathy (AOC). AOC is characterized by very high plasmin/antiplasmin complexes and rapid depletion of functional fibrinogen and factor V (FV). To determine mechanisms underlying AOC, we investigated the plasma from 12 women with AOC (defined by raised plasmin/antiplasmin) and 21 with severe PPH (blood loss >2000 mL or placental abruption) without AOC. Plasma from patients with AOC had a fourfold increased ability to generate plasmin compared with those with severe PPH without AOC (P < .0002). AOC was associated with fibrinogen cleavage in the circulation, demonstrated by fragment D and other breakdown products (P < .0001). D-dimer was increased 36-fold in AOC compared with severe PPH without AOC, thrombin/antithrombin complexes were not raised. FV was reduced on western blot in AOC but not severe PPH without AOC (P < .001) suggesting FV cleavage. Confocal microscopy revealed similar clot structure between AOC and non-AOC samples, but both groups differed from nonbleeding pregnant controls. These data suggest that in AOC an excess of plasmin cleaves fibrinogen and FV in the circulation causing a specific, pathognomonic depletion of coagulation factors. Fibrin(ogen) breakdown products have cofactor function for tissue plasminogen activator, and these data are consistent with these breakdown products, enhancing plasmin generation and potentially driving aberrant plasmin generation in AOC. These results have implications for the clinical management of coagulopathy during PPH.

Indexed as

Blood Coagulation DisordersFactor VFibrinogenFibrinolysinPostpartum HemorrhageAcute DiseaseAdultFemaleFibrin Fibrinogen Degradation ProductsHumansPregnancyProteolysisFactor VFibrin Fibrinogen Degradation ProductsFibrinogenFibrinolysin

Identifiers

PMID39913691
PMCPMC12166374

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.